NCT01243333 2024-04-17
Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors
University of Utah
Phase NA Terminated
Clinical Trials
10 trialsNCT02167204 2020-01-13
18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
University of Washington
Phase NA Completed
NCT02139150 2019-09-17
Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy
Memorial Sloan Kettering Cancer Center
Phase NA Withdrawn
NCT00276770 2019-02-27
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
University of Washington
Phase NA Completed
NCT01928186 2018-05-15
FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer
University of Washington
Phase NA Completed
NCT01222416 2017-07-02
PET/CT Evaluation of Treatment Response in Breast Cancer
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
NCT02241668 2016-02-26
Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT01018251 2015-12-15
Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Withdrawn
NCT00534274 2014-12-16
Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy
UNICANCER
Phase NA Completed
NCT01713049 2012-10-24
18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound
National Taiwan University Hospital
Phase NA Unknown